Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.31 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL775482 | 0.85 | LTA4H (0.45) | LTA4HTSHRCA4CA1CA2 | |
| SCHEMBL29524127 | 0.80 | LTA4H (0.41) | LTA4HTSHRCA4CA1CA2 | |
| SCHEMBL2836966 | 0.76 | CA4 (0.46) | LTA4HTSHRCA4CA1CA2 | |
| SCHEMBL5846748 | 0.75 | LTA4H (0.41) | LTA4HTSHRCA4CA1CA2 | |
| SCHEMBL28098825 | 0.74 | CA4 (0.44) | LTA4HTSHRCA4CA1CA2 | |
| SCHEMBL27976833 | 0.73 | LTA4H (0.39) | LTA4HTSHRCA4CA1CA2 | |
| SCHEMBL776256 | 0.73 | FFAR1 (0.41) | LTA4HTDP1L3MBTL1ALOX15EPHX2 | |
| SCHEMBL3884014 | 0.73 | HTT (0.48) | TSHRCA1CA2CA9ACHE | |
| SCHEMBL27448179 | 0.73 | TAAR1 (0.40) | LTA4HTSHRCA1CA2CA9 | |
| SCHEMBL11082104 | 0.71 | CA1 (0.47) | CA1CA2CA9TDP1CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0079703-B1 | CURING COMPOSITIONS | Lingner + Fischer GmbH (DE) | 1986-09-10 | — | — | EP | claimed |
| US-4467079-A | UNSATURATED MONOMER, POLYMERIZATION CATALYSTS | LINGNER & FISCHER GMBH (DE) | 1984-08-21 | — | — | US | claimed |
| EP-0079703-A1 | Curing compositions | Lingner + Fischer GmbH (DE) | 1983-05-25 | — | — | EP | claimed |
| CN-119350379-A | Triphenylboric acid Process for the preparation of esters | 上海若济生物医药科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| US-7022833-B2 | Process for the preparation of phosphorothioate triesters | AVECIA LIMITED (GB) | 2006-04-04 | — | — | US | disclosed |
| US-7019127-B2 | Solution phase synthesis of oligonucleotides | AVECIA LIMITED (GB) | 2006-03-28 | — | — | US | disclosed |
| US-20050240015-A1 | Solution phase synthesis of oligonucleotides | AVECIA LIMITED (GB) | 2005-10-27 | — | — | US | disclosed |
| EP-1272501-B1 | PROCESS FOR THE PREPARATION OF PHOSPHOROTHIOATE TRIESTERS | AVECIA LTD (GB) | 2004-05-06 | — | — | EP | disclosed |
| EP-1325927-A2 | Synthesis of oligonucleotides | Avecia Limited (GB) | 2003-07-09 | — | — | EP | disclosed |
| US-20030099981-A1 | Process for the preparation of phosphorothioate triesters | NITTO DENKO AVECIA, INC. | 2003-05-29 | — | — | US | disclosed |
| EP-1066249-B1 | PROCESS FOR THE MANUFACTURE OF CYCLOPROPANECARBONITRILE | EASTMAN CHEM CO (US) | 2003-05-07 | — | — | EP | disclosed |
| WO-1997003949-A1 | PROCESS FOR THE PREPARATION AND SEPARATION OF CYCLOPROPANECARBONITRILE | EASTMAN CHEMICAL COMPANY (US) | 1997-02-06 | — | — | WO | disclosed |
| US-5502234-A | FROM CYCLOPROPANECARBOXALDEHYDE AND HYDROXYLAMINE | EASTMAN CHEMICAL COMPANY (US) | 1996-03-26 | — | — | US | disclosed |
| EP-0079703-B1 | CURING COMPOSITIONS | Lingner + Fischer GmbH (DE) | 1986-09-10 | — | — | EP | disclosed |
| US-4467079-A | UNSATURATED MONOMER, POLYMERIZATION CATALYSTS | LINGNER & FISCHER GMBH (DE) | 1984-08-21 | — | — | US | disclosed |
| EP-0079703-A1 | Curing compositions | Lingner + Fischer GmbH (DE) | 1983-05-25 | — | — | EP | disclosed |
| US-4259462-A | Hardenable composition containing diisopropylbenzene dihydroperoxide | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1981-03-31 | — | — | US | disclosed |
| US-4174311-A | Hardenable composition containing diisopropylbenzene dihydroperoxide | DENKI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1979-11-13 | — | — | US | disclosed |
| US-4069340-A | ARYLOXY DIMETHYL IMMONIUM CHLORIDES FROM DIMETHYL FORMAMIDE AND CORRESPONDING ARYL CHLOROFORMATES | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1978-01-17 | — | — | US | disclosed |
| US-3983178-A | Immonium salts and derivatives thereof | HOOKER CHEMICALS & PLASTICS CORPORATION (US) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050240015-A1 | Solution phase synthesis of oligonucleotides | NUDT1, POLR2E, POLRMT | LTA4H 2321/4885TSHR 1672/4885CA4 3062/4885 |
| US-20030099981-A1 | Process for the preparation of phosphorothioate triesters | OSGEP, NUDT1, PNKP | LTA4H 2532/4885TSHR 1257/4885CA4 2960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.